Elicio Therapeutics, Inc. Debt Instrument, Convertible, Conversion Price
Elicio Therapeutics, Inc. (ELTX) had Debt Instrument, Convertible, Conversion Price of $11.57 per share as of 2021-02-09, per its 10-K filed 2022-03-30.
Discontinued › Notes
us-gaap:DebtInstrumentConvertibleConversionPrice1 · last filed 2022-03-30
- 2021-02-09: Debt Instrument, Convertible, Conversion Price $11.57.
| Period end | Debt Instrument, Convertible, Conversion Price |
|---|---|
| 2021-02-09 | $11.57 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |